1. Home
  2. CPIX vs PMN Comparison

CPIX vs PMN Comparison

Compare CPIX & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CPIX
  • PMN
  • Stock Information
  • Founded
  • CPIX 1999
  • PMN 2004
  • Country
  • CPIX United States
  • PMN Canada
  • Employees
  • CPIX N/A
  • PMN N/A
  • Industry
  • CPIX Biotechnology: Pharmaceutical Preparations
  • PMN Pharmaceuticals and Biotechnology
  • Sector
  • CPIX Health Care
  • PMN Health Care
  • Exchange
  • CPIX Nasdaq
  • PMN Nasdaq
  • Market Cap
  • CPIX 68.7M
  • PMN 29.8M
  • IPO Year
  • CPIX 2009
  • PMN N/A
  • Fundamental
  • Price
  • CPIX $6.62
  • PMN $0.90
  • Analyst Decision
  • CPIX
  • PMN
  • Analyst Count
  • CPIX 0
  • PMN 0
  • Target Price
  • CPIX N/A
  • PMN N/A
  • AVG Volume (30 Days)
  • CPIX 4.2M
  • PMN 43.2K
  • Earning Date
  • CPIX 03-04-2025
  • PMN 03-31-2025
  • Dividend Yield
  • CPIX N/A
  • PMN N/A
  • EPS Growth
  • CPIX N/A
  • PMN N/A
  • EPS
  • CPIX N/A
  • PMN N/A
  • Revenue
  • CPIX $36,785,442.00
  • PMN N/A
  • Revenue This Year
  • CPIX N/A
  • PMN N/A
  • Revenue Next Year
  • CPIX N/A
  • PMN N/A
  • P/E Ratio
  • CPIX N/A
  • PMN N/A
  • Revenue Growth
  • CPIX N/A
  • PMN N/A
  • 52 Week Low
  • CPIX $1.04
  • PMN $0.87
  • 52 Week High
  • CPIX $6.43
  • PMN $2.61
  • Technical
  • Relative Strength Index (RSI)
  • CPIX 65.49
  • PMN 50.80
  • Support Level
  • CPIX $4.12
  • PMN $0.90
  • Resistance Level
  • CPIX $5.30
  • PMN $1.03
  • Average True Range (ATR)
  • CPIX 0.78
  • PMN 0.05
  • MACD
  • CPIX 0.11
  • PMN 0.00
  • Stochastic Oscillator
  • CPIX 68.74
  • PMN 40.00

About CPIX Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's primary target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.

About PMN ProMIS Neurosciences Inc. (ON)

ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine is based on the use of two complementary techniques. The company applies its thermodynamic, computational discovery platform-ProMIS and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.

Share on Social Networks: